The Tamiflu Fraud

Scientists attempting to peer review the paper requested vital data, and did not get it. Tonight we report a key plank of the evidence for Tamiflu's effectiveness is being called into question.

As swine flu hit the UK, the anti-viral drug Tamiflu hit the headlines, becoming the de facto first line of defence against the epidemic.

It was lauded for reducing the length and duration of flu-like illnesses and, importantly, for reducing hospitalisations.

Governments around the world stockpiled supplies. In the UK alone the estimated bill for Tamiflu is approaching half a billion pounds.

Tonight Channel 4 News can reveal that serious scientific questions are being raised over the evidence base for Tamiflu.'

Read more...